a.adebayo

TL2 · Braga

Contributes reviews on supplier material. Based in Braga.

Joined 16 March 2025 · last posted 4d

78 posts, newest first. Showing up to 150.

Submitting a sample: the process end to end Replied, post #108 · Sourcing › Independent verification · 24 Jul 2026 · 19 likes Adding what did not work for me on submitting a sample, since the failures never get written up and they are half the useful information.
What to bring: records that a clinician can actually use — a second dataset Replied, post #45 · Clinical › Prescriber conversations · 17 Jul 2026 · 6 likes Asking about the plan if the first approach does not work is a good use of an appointment and is rarely done. I have said this before in a thread nobody could find, so…
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #19 · Analytics › Home & field testing · 11 Jul 2026 · 28 likes Post #17 and I disagree about the size of the effect, not about the direction. An honest declaration on Cost versus information: I have a prior here and it is strong…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #43 · Compounds › Retatrutide · 7 Jul 2026 · 0 likes Bookmarking this. I will come back when I have something worth adding.
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #43 · Analytics › Home & field testing · 30 Jun 2026 · 7 likes Post #42 put the caveat in the right place and I want to underline it. The right question for any home test is: what physical quantity does it measure, and what would…
[2026 update] Temperature indicator cards: worth asking for? Replied, post #11 · Sourcing › Logistics · 26 Jun 2026 · 1 like Building on post #10 rather than restating it. Two sentences on Temperature indicator cards and then I will stop, because the rest is speculation and the thread is…
Follow-up: Reconciling a label claim with a content assay Replied, post #27 · Analytics › COA interpretation · 23 Jun 2026 · 0 likes Everything in post #25 holds. The case it does not cover is the one I have. I changed my mind about Reconciling a label claim after someone here asked me for the source…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #134 · Practice › Storage & stability · 14 Jun 2026 · 1 like If you are new and reading this thread for the answer to Storing lyophilised material long term: the answer is conditional, the conditions are in the third reply, and…
An appeal that succeeded, with the letter structure — the long version Replied, post #89 · Access › Insurance & coverage · 12 Jun 2026 · 20 likes Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer.
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #72 · Practice › Administration · 10 Jun 2026 · 0 likes Bleeding at the site is common and unremarkable at these needle gauges. Persistent bruising in the same area repeatedly is worth a change of technique or of site rather…
Second pass at: Metformin co-administration and additive GI effects Replied, post #99 · Practice › Interactions · 6 May 2026 · 3 likes Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not…
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #23 · Analytics › Mass spectrometry · 2 May 2026 · 32 likes Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the commonest overclaim in this subcategory.
The "under review" status pill and when a moderator applies it Replied, post #102 · Evidence › Preprints · 29 Apr 2026 · 0 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.
The "under review" status pill and when a moderator applies it Replied, post #82 · Evidence › Preprints · 19 Apr 2026 · 1 like Good question, well framed, and I would like to see it answered properly.
The "under review" status pill and when a moderator applies it Replied, post #67 · Evidence › Preprints · 11 Apr 2026 · 22 likes Sensible. I would want the same detail before I acted on it either.
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #63 · Research Methods › N-of-1 designs · 9 Apr 2026 · 19 likes Committing to post the result before you know it is a useful precommitment, and this subcategory is a reasonable place to make it. It is a small point and it changes…
Conditions that change the calculus rather than forbidding it Replied, post #6 · Safety › Contraindications · 31 Mar 2026 · 12 likes Post #5 is the version of this I will quote in future. One addition. Adding a null result on conditions. I looked, carefully, and found nothing, and null results…
Choosing which test to pay for, given a fixed budget Replied, post #38 · Sourcing › Independent verification · 24 Mar 2026 · 31 likes This follows post #37 rather than contradicting it. The record shows what was measured. Everything beyond that is inference and this site tries to keep the line…
Validating a method you did not develop Replied, post #12 · Analytics › Method validation · 15 Mar 2026 · 3 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
Contributing data without breaching anyone's privacy Replied, post #46 · Data & Tools › Datasets · 5 Mar 2026 · 3 likes Distinguishing three things in the contributing data without breaching discussion that keep getting used interchangeably: the observation, the proposed mechanism, and…
The headache that turns out to be dehydration — the long version Replied, post #4 · Nutrition & Training › Hydration & electrolytes · 26 Feb 2026 · 15 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. Symptoms attributed to electrolytes here are non-specific and overlap with…
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #11 · Outcomes › Progress reports · 21 Feb 2026 · 0 likes Post #8 answers the question as asked. The question underneath it is different. Rate of change matters more than the absolute number for most of the questions people…
[2026 update] What a purity-only report leaves out Replied, post #20 · Sourcing › Independent verification · 9 Feb 2026 · 16 likes On post #18 — agreed on the reasoning, with one qualification. The question underneath purity-only is usually "how would I tell?" rather than "what is true?", and that…
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #20 · Evidence › Trials · 2 Feb 2026 · 7 likes Helpful, and easy to find again, which is half of what a good reply is.
Pregnancy and pregnancy planning: contraindication and washout Replied, post #29 · Clinical › Special populations · 31 Jan 2026 · 0 likes Taking post #26 at face value and following it one step further. Speaking only to pregnancy and pregnancy planning as I have actually seen it, rather than as it is…
Preprint servers and what screening they do Replied, post #33 · Evidence › Preprints · 24 Jan 2026 · 6 likes Say it is a preprint in the first line rather than the last. Everything downstream depends on that status and readers arriving from search will not scroll for it.…
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #20 · Sourcing › Logistics · 11 Jan 2026 · 14 likes Narrowing post #17, because the general version has more than one answer. Anyone deciding whether a delay is a problem should ask what would change if they waited…
Second pass at: Which categories are strict and which are relaxed, honestly Started this topic · Start Here › Welcome · 7 Jan 2026 · 5 likes On the subject in the title: Second pass at: Which categories are strict and which are relaxed, honestly Working notes rather than a conclusion. Checking my reasoning…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #44 · Access › International · 7 Jan 2026 · 5 likes Regional practice around what a pharmacy will and will not do varies enormously and is not deducible from the regulatory position. Nothing above should be read as…
Second pass at: The topic list is dense — is that deliberate? Replied, post #33 · Meta › Site feedback · 1 Jan 2026 · 6 likes Post #31 is right about the mechanism and I think understates the practical bit. Reporting a real defect: on a long topic the jump-to-post link scrolls to the right…
Hair shedding at month three: mechanism and time course Replied, post #3 · Practice › Side effects · 31 Dec 2025 · 2 likes Picking up post #2: that is the part I would want checked first. Hair shedding some months in is described frequently here and is more consistent with rapid weight loss…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #119 · Compounds › Oral incretins · 30 Dec 2025 · 0 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
Reading SURMOUNT-1 without the press release Replied, post #120 · Compounds › Tirzepatide · 30 Dec 2025 · 0 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
Where impurities in solid-phase peptide synthesis come from Replied, post #27 · Analytics › Impurities & related substances · 15 Dec 2025 · 3 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #85 · Compounds › Tirzepatide · 12 Dec 2025 · 25 likes Tirzepatide's half-life of roughly five days means steady state is approached in about three weeks rather than four. That is a real difference from semaglutide and it…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #34 · Clinical › Special populations · 18 Nov 2025 · 0 likes On post #32 — agreed on the reasoning, with one qualification. Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent…
The anatomy of a question that gets answered within an hour — the long version Replied, post #98 · Start Here › How to Ask · 15 Nov 2025 · 19 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. I have separated what I observed from…
Where to report an adverse event officially, by region — a second dataset Replied, post #104 · Safety › Adverse events · 7 Nov 2025 · 7 likes The arithmetic in post #103 is right; the assumption feeding it is the part to check. Where an event resolved, saying how and how long it took is as useful as the event…
Guidelines revision: what changed and why — one year on Replied, post #31 · Meta › Announcements · 1 Nov 2025 · 0 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when. Not a conclusion. A place to stand while looking…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #103 · Lounge › Off topic · 17 Oct 2025 · 3 likes Since the Lounge tolerates a digression: the thing I find most interesting about this community is how much of the useful material is negative. Half the value is…
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #89 · Analytics › HPLC & UHPLC · 30 Sep 2025 · 21 likes That is the distinction I keep failing to hold on to. Written down now.
Documentation that appears only after payment Replied, post #34 · Sourcing › Red flags · 26 Sep 2025 · 21 likes I read post #30 twice before replying, because I had assumed the opposite. My experience of documentation contradicts the reply above. I am posting it as a data point…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #109 · Data & Tools › Datasets · 10 Sep 2025 · 19 likes Aggregated purity results across four has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done…
Coming back to: What happens when a maintainer goes quiet Replied, post #9 · Documentation › Doc review · 9 Sep 2025 · 0 likes Post #6 is the version of this I will quote in future. One addition. Approving a document you have not read is worse than not responding, and it happens because…
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #42 · Compounds › Secretagogues & GH axis · 31 Aug 2025 · 9 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #24 · Analytics › COA interpretation · 23 Aug 2025 · 1 like Useful. I had the fact and not the reason, which turns out to be the important half.
Titles that describe the question, not the situation Replied, post #70 · Start Here › How to Ask · 13 Aug 2025 · 0 likes Two people in this thread mean different things by titles and are disagreeing about the definition while believing they are disagreeing about the facts. Worth pausing…
Travel coolers and how long they really hold Replied, post #45 · Devices › Cold chain · 4 Aug 2025 · 1 like Thank you for taking the time. That was more work than a reply usually is.
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #38 · Practice › Reconstitution · 1 Aug 2025 · 5 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
Coming back to: Official shortage notices and what they authorise Replied, post #55 · Access › Shortages · 12 Jul 2025 · 28 likes Both are useful and different. The notice tells you the national position; the account tells you what is happening on the ground. I have seen it go both ways, which is…
Persistent vomiting and the threshold for seeking help Replied, post #3 · Safety › Adverse events · 6 Jul 2025 · 7 likes Post #2 answers the question as asked. The question underneath it is different. Pancreatitis is a genuine serious adverse event to know: severe epigastric pain, back…
Repeatability versus intermediate precision Replied, post #56 · Analytics › Method validation · 24 Jun 2025 · 17 likes Helpful, and short, which on this subject is harder than long.
A ten-fold dose error caught before injection Replied, post #50 · Devices › Syringes & needles · 16 Jun 2025 · 14 likes The arithmetic in post #49 is right; the assumption feeding it is the part to check. A detachable luer needle plus hub can retain enough volume to matter. Whether it…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #27 · Evidence › Journal club · 8 Jun 2025 · 2 likes Post #25 describes the usual case. This is about the unusual one. Sessions on negative or null results are consistently the most instructive and the hardest to get…
An orphaned page with no inbound links Replied, post #47 · Meta › Wiki maintenance · 30 May 2025 · 0 likes Trying to state the orphaned page position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that…
Coverage for the indication versus for the drug Replied, post #71 · Access › Insurance & coverage · 18 May 2025 · 30 likes Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and…
Validating a calculator against hand arithmetic — what changed since Replied, post #63 · Data & Tools › Calculators · 11 May 2025 · 7 likes Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
Units, standards, and other things that quietly hold the world together Replied, post #28 · Lounge › Off topic · 25 Apr 2025 · 1 like Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that.…
Certificates issued by the seller versus by a laboratory Replied, post #37 · Analytics › COA interpretation · 9 Apr 2025 · 21 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
Deamidation and the close-eluting pair it produces Replied, post #12 · Analytics › Impurities & related substances · 21 Mar 2025 · 0 likes Post #9 and I disagree about the size of the effect, not about the direction. Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier.…
Coverage for the indication versus for the drug Started this topic · Access › Insurance & coverage · 12 Mar 2025 · 22 likes Coverage for the indication versus for the drug — setting out what I have, and where I think it stops being reliable. The question about coverage that I actually want…
Counter-ion form: the field almost nobody reports — one year on Replied, post #8 · Analytics › COA interpretation · 18 Feb 2025 · 22 likes Agreed on Counter-ion form, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not,…
Distinguishing a deletion sequence by mass alone Replied, post #88 · Analytics › Mass spectrometry · 14 Feb 2025 · 2 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
Coming back to: An 18-month record including the parts that went badly Replied, post #17 · Outcomes › Progress reports · 14 Feb 2025 · 4 likes Trying to state the 18-month record position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #92 · Analytics › COA interpretation · 31 Jan 2025 · 32 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #9 · Access › International · 22 Jan 2025 · 23 likes The arithmetic in post #8 is right; the assumption feeding it is the part to check. Where a jurisdiction has published guidance for clinicians, that document usually…
Escalating every six weeks instead of four: what I observed over eight months Replied, post #28 · Practice › Dosing & titration · 20 Jan 2025 · 32 likes Dose and effect are not linear across the studied range for every compound in this class. Assuming a doubled dose gives a doubled effect is the reasoning error behind…
Recovery when intake is low: what to cut first Replied, post #24 · Nutrition & Training › Resistance training · 10 Jan 2025 · 3 likes Reduced appetite makes fuelling a session harder, and that is a practical problem with practical solutions rather than a reason to stop. I would want the raw data…
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #21 · Compounds › Oral incretins · 4 Jan 2025 · 1 like Good question, well framed, and I would like to see it answered properly.
Talking to a therapist about this specifically — does this still hold? Replied, post #2 · Wellbeing › Mental health · 2 Jan 2025 · 17 likes Maintenance brings a different set of psychological questions from loss, and the discussion here is much thinner on that phase.
UK access routes, dated and sourced — a second dataset Replied, post #14 · Regional › UK & Ireland · 8 Dec 2024 · 22 likes Where the compound is supplied with a device, the device and the compound have separate availability positions and the device is more often the constraint. The…
Why I ask for the gradient before I discuss the number Replied, post #40 · Analytics › HPLC & UHPLC · 30 Nov 2024 · 0 likes Noted, and thank you for writing it out rather than summarising it.
[2026 update] New subcategory: rationale and scope Replied, post #20 · Meta › Announcements · 23 Nov 2024 · 0 likes Before the thread moves on from New subcategory — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of…
Progressive overload when the scale is falling — one year on Replied, post #70 · Nutrition & Training › Resistance training · 19 Sep 2024 · 16 likes Appreciated. The plain phrasing does more work here than a longer post would.
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #24 · Compounds › Retatrutide · 7 Sep 2024 · 2 likes Discontinuation for adverse effects in phase 2 was not negligible at the higher doses. That figure belongs next to the efficacy figure whenever the efficacy figure is…
Circumference measurements as a poor man's composition estimate Replied, post #95 · Outcomes › Body composition · 24 Aug 2024 · 0 likes Post #94 describes the usual case. This is about the unusual one. The most useful protocol is the one you will actually repeat identically. An imperfect measurement…
The C-cell question: rodent findings and their human context — what changed since Replied, post #20 · Compounds › Semaglutide · 24 Aug 2024 · 0 likes I read post #18 twice before replying, because I had assumed the opposite. The reason c-cell question keeps being re-asked is that the answer is conditional and people…
Assessing a warm arrival: the decision process — one year on Replied, post #18 · Sourcing › Logistics · 28 May 2024 · 0 likes Reading this Assessing a warm arrival thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.